Average Co-Inventor Count = 6.42
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Ucbbiopharma Srl (12 from 109 patents)
2. Ucb Pharma, S.a. (3 from 179 patents)
3. Ucb Biopharma Sprl (3 from 138 patents)
4. Sanofi (2 from 1,454 patents)
18 patents:
1. 12410244 - Anti-alpha-synuclein antibodies
2. 12055549 - Methods of use of anti-TNFα antibodies
3. 11674967 - Method of identifying potential inhibitors of APO TNFα trimers
4. 11518803 - Antagonist antibodies that bind to human TGFB1, TGFB2 and to TGFB3 and their use for the treatment of lung fibrosis
5. 11292831 - Anti-alpha synuclein antibodies
6. 11261242 - Anti-alpha-synuclein antibodies
7. 11174311 - Antibody against trimeric TNFα complex
8. 11091542 - Antibody molecules which bind TNF alpha
9. 11022614 - Antibodies binding to trimeric TNF alpha epitopes
10. 10969393 - Complexes between anti-TNF antibodies, trimeric TNF proteins and organic molecules binding them
11. 10775385 - Treatment of autoimmune and inflammatory disorders with asymmetric TNF alpha trimers
12. 10766956 - Antagonist antibodies that bind to human TGFB1, TGFB2 and to TGFB3 and their use for the treatment of lung fibrosis
13. 10752676 - Neutralising antibodies to the major exotoxins TCDA and TCDB of
14. 9957320 - Isolated DNA sequences encoding, and methods for making, antibody molecules having binding specificity for human IL-13
15. 9394361 - Isolated DNA sequences encoding, and methods for making, antibody molecules having binding specificity for human IL-13